As of June 18, 2025, Cooper Companies Inc (COO) reports a Net Margin of 10.07%.
Net Margin shows the share of revenue that becomes profit after all costs, reflecting overall profitability.
Historical Trend of Cooper Companies Inc's Net Margin
Over recent years, Cooper Companies Inc's Net Margin has shown significant volatility. The table below summarizes the historical values:
| Date | Net Margin |
|---|---|
| 2024-10-31 | 10.07% |
| 2023-10-31 | 8.19% |
| 2022-10-31 | 11.66% |
| 2021-10-31 | 100.76% |
| 2020-10-31 | 9.81% |
This slight upward trend highlights how Cooper Companies Inc manages its overall profitability and cost control over time.
Comparing Cooper Companies Inc's Net Margin to Peers
To better understand Cooper Companies Inc's position, it's useful to compare its Net Margin against industry peers. Below are selected comparisons:
| Company | Net Margin |
|---|---|
| Cooper Companies Inc (COO) | 10.07% |
| Utah Medical Products Inc (UTMD) | 33.92% |
| Antares Pharma Inc (ATRS) | 25.16% |
| Lantheus Holdings Inc (LNTH) | 20.37% |
| West Pharmaceutical Services Inc (WST) | 17.03% |
| Meridian Bioscience Inc (VIVO) | 12.75% |
Compared to its competitors, Cooper Companies Inc's Net Margin is about average compared to peers, reflecting typical industry profitability.